Commentaries by date:

Risk of Bias in Randomized Trials

By Gordon H Guyatt, MD, MSc and Jason W Busse, DC, PhD | Jun 15, 2016

Assessing the Evidence Series By Gordon H. Guyatt, MD, MSc and Jason W. Busse, DC, PhD Risk of Bias: A Better…

Read More

Evaluating Systematic Review Quality

By Diekemper et all. | May 15, 2016

Assessing the Evidence Series By Rebecca L Diekemper, MPH, Doctor Evidence, Santa Monica, CA, Belinda K Ireland, MD, MS, TheEvidenceDoc,…

Read More

Assessing the Evidence: Series Launch

By Craig Whittington, PhD and Jacob Franek | Apr 15, 2016

By Craig Whittington, PhD and Jacob Franek, MHSc Introduction GROWTH commentaries started in November 2014, and have covered a broad…

Read More

Putting the Evidence into AHRQ’s EvidenceNOW

By David Meyers, MD | Mar 15, 2016

By David Meyers, M.D. Chief Medical Officer, AHRQ Introduction One of my favorite things about attending large conferences is bumping…

Read More

Implementing Person-Centered Care through Guidelines

By Anna R. Gagliardi, PhD | Feb 15, 2016

By Anna R Gagliardi, PhD  Scientist, Toronto General Hospital Research Institute, University Health Network Associate Professor, University of Toronto Chair,…

Read More

The Power of Reliable Evidence

By Michael E. Stuart MD, and Sheri Ann Strite | Oct 15, 2015

Changing medical culture and providing care providers and patients with needed information, thereby achieving quality, value, and truly informed consent…

Read More

The Institute of Medicine Standards for Systematic Reviews: 4 Years Later

By Sally C. Morton, PhD | Sep 15, 2015

By Sally C. Morton, PhD Professor and Chair, Department of Biostatistics University of Pittsburgh Vice Chair, IOM Committee on Standards for…

Read More

What is the impact of the IOM Clinical Practice Guidelines Report on consumer stakeholder involvement?

By Peg Ford | Aug 15, 2015

By Peg Ford, Co-Founder/President Ovarian Cancer Alliance of San Diego My entry into the world of medical research was due to a…

Read More

Effects of the IOM Reports: A Guideline Developer’s Perspective

By Tom Oliver | Jul 15, 2015

By Tom Oliver, Director Quality and Guidelines, American Society of Clinical Oncology Introduction The Guideline Program of the American Society of Clinical Oncology (ASCO)…

Read More